Cognyte Q2 FY27: Strong Headline, But Recurring Revenue and RPO Need Scrutiny

What happened

Cognyte reported second-quarter FY2027 results that management characterizes as strong, citing accelerating software growth and expanding profitability. The press release headline is promotional and lacks specific metrics, so the market must verify whether revenue growth is driven by recurring subscriptions or one-time software sales. Prior quarters showed recurring revenue growth of only ~3% year over year, which failed to support the subscription-transition thesis. Investors should look for short-term remaining performance obligations (RPO) to increase sequentially from $369.5 million and total RPO to expand from $557.2 million. Without confirmation of these leading indicators, the reported strength may still reflect lumpy nonrecurring deals.

Implication

The strong Q2 results could validate the operating leverage and software momentum if accompanied by rising short-term RPO and billings growth. However, if recurring revenue growth remains in the low single digits and the increase is driven by nonrecurring software, the investment thesis remains challenged. Cognyte's own filings warn that subscription adoption may be slower and less predictable, and RPO may not be a meaningful indicator due to cancellations. The next earnings call and disclosure of backlog details will be critical to assess whether the company is converting wins into durable, recurring revenue. Until then, the stock may react positively to the headline, but fundamental conviction should be tempered.

Thesis delta

The prior POTENTIAL BUY thesis rested on confirming short-term RPO stability and recurring revenue acceleration within two quarters. The Q2 headline suggests improvement, but without disclosed numbers, the thesis cannot be upgraded. A positive shift would require recurring revenue growth above 10% and short-term RPO rising more than 5% sequentially; a negative shift would occur if these metrics disappoint despite the upbeat tone.